Good to read the references down the bottom.
So would this proposal from investigator initiated study be on the back of the Israel results?
Is Astex decitabine one of the drugs coming out of patent that would benefit from co-formulation?
Will there be communications on who the investigator is in this trial.
Sorry if there are answers to this already that i may have missed!
Ann: Updated Strategy and Investor Presentation, page-42
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |